FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225552425> ?p ?o ?g. }

• W4225552425 endingPage "773" @default.
• W4225552425 startingPage "761" @default.
• W4225552425 abstract "A clinical-genomic prognostic multigene panel (RI-DR assay, RecurIndex®), predicting the risk level of distant recurrence (DR) in early-stage breast cancer (EBC) patients with an Asian background, has been validated as a valuable tool for identifying high-risk patients to develop distant recurrence (metastasis). Although the clinical benefit of adjuvant chemotherapy from the assay's prediction is already proved, its affordability remains uncertain. This study is the first time in which the long-term cost-effectiveness of the RI-DR assay is evaluated.A lifetime Markov decision-analytic model was developed from a societal perspective to estimate the life-years gained (LYGs), quality-adjusted life-years (QALYs), medical costs, and incremental cost-effectiveness ratios (ICERs), comparing EBC women with and without RI-DR genomic testing. A decision tree was used to classify patients in one of the fifteen end nodes (by order, each arm was stratified by a patient being tested or not with the RI-DR assay, being treated or not with adjuvant chemotherapy and had no, minor, major, or fatal toxicity after adjuvant chemotherapy). Health utilities, costs, transition probabilities, and survival data were extracted from the scientific literature. Deterministic sensitivity analysis (DSA) and probabilistic sensitivity analysis (PSA) were performed on variables to assess the robustness of the model. A willingness-to-pay (WTP) threshold of 790,000 NT$ per QALY gained was considered as a cost-effectiveness criterion.The incremental cost per QALY gained under base-case assumptions of the model was 173,842 NT$. Findings on the variation in model input parameters were robust and confirmed that every key variable was cost-effective for the benefit of RI-DR testing.The clinical-genomic RI-DR assay is cost-effective in guiding adjuvant chemotherapy decisions compared to current clinical practice guidelines." @default.
• W4225552425 created "2022-05-05" @default.
• W4225552425 creator A5024042121 @default.
• W4225552425 creator A5029550793 @default.
• W4225552425 creator A5039911969 @default.
• W4225552425 creator A5054227944 @default.
• W4225552425 creator A5067831910 @default.
• W4225552425 date "2022-02-01" @default.
• W4225552425 modified "2023-09-25" @default.
• W4225552425 title "Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer" @default.
• W4225552425 cites W1549906179 @default.
• W4225552425 cites W1861968676 @default.
• W4225552425 cites W2024912874 @default.
• W4225552425 cites W2063841790 @default.
• W4225552425 cites W2070786367 @default.
• W4225552425 cites W2077299691 @default.
• W4225552425 cites W2080558042 @default.
• W4225552425 cites W2083224152 @default.
• W4225552425 cites W2095950656 @default.
• W4225552425 cites W2105882193 @default.
• W4225552425 cites W2113344831 @default.
• W4225552425 cites W2127178682 @default.
• W4225552425 cites W2127307780 @default.
• W4225552425 cites W2128985829 @default.
• W4225552425 cites W2133953673 @default.
• W4225552425 cites W2137053366 @default.
• W4225552425 cites W2159307742 @default.
• W4225552425 cites W2160377567 @default.
• W4225552425 cites W2164654252 @default.
• W4225552425 cites W2225225424 @default.
• W4225552425 cites W2279508837 @default.
• W4225552425 cites W2318393109 @default.
• W4225552425 cites W2405317301 @default.
• W4225552425 cites W2751875990 @default.
• W4225552425 cites W2767424685 @default.
• W4225552425 cites W2800306278 @default.
• W4225552425 cites W2801583052 @default.
• W4225552425 cites W2912993657 @default.
• W4225552425 cites W2920863604 @default.
• W4225552425 cites W2958073179 @default.
• W4225552425 cites W2960282589 @default.
• W4225552425 cites W3010648853 @default.
• W4225552425 cites W3028070213 @default.
• W4225552425 cites W3128646645 @default.
• W4225552425 doi "https://doi.org/10.2147/cmar.s339549" @default.
• W4225552425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35250309" @default.
• W4225552425 hasPublicationYear "2022" @default.
• W4225552425 type Work @default.
• W4225552425 citedByCount "0" @default.
• W4225552425 crossrefType "journal-article" @default.
• W4225552425 hasAuthorship W4225552425A5024042121 @default.
• W4225552425 hasAuthorship W4225552425A5029550793 @default.
• W4225552425 hasAuthorship W4225552425A5039911969 @default.
• W4225552425 hasAuthorship W4225552425A5054227944 @default.
• W4225552425 hasAuthorship W4225552425A5067831910 @default.
• W4225552425 hasBestOaLocation W42255524251 @default.
• W4225552425 hasConcept C112930515 @default.
• W4225552425 hasConcept C121608353 @default.
• W4225552425 hasConcept C126322002 @default.
• W4225552425 hasConcept C143998085 @default.
• W4225552425 hasConcept C146357865 @default.
• W4225552425 hasConcept C151730666 @default.
• W4225552425 hasConcept C29456083 @default.
• W4225552425 hasConcept C3019080777 @default.
• W4225552425 hasConcept C515549039 @default.
• W4225552425 hasConcept C530470458 @default.
• W4225552425 hasConcept C71924100 @default.
• W4225552425 hasConcept C86803240 @default.
• W4225552425 hasConceptScore W4225552425C112930515 @default.
• W4225552425 hasConceptScore W4225552425C121608353 @default.
• W4225552425 hasConceptScore W4225552425C126322002 @default.
• W4225552425 hasConceptScore W4225552425C143998085 @default.
• W4225552425 hasConceptScore W4225552425C146357865 @default.
• W4225552425 hasConceptScore W4225552425C151730666 @default.
• W4225552425 hasConceptScore W4225552425C29456083 @default.
• W4225552425 hasConceptScore W4225552425C3019080777 @default.
• W4225552425 hasConceptScore W4225552425C515549039 @default.
• W4225552425 hasConceptScore W4225552425C530470458 @default.
• W4225552425 hasConceptScore W4225552425C71924100 @default.
• W4225552425 hasConceptScore W4225552425C86803240 @default.
• W4225552425 hasLocation W42255524251 @default.
• W4225552425 hasLocation W42255524252 @default.
• W4225552425 hasLocation W42255524253 @default.
• W4225552425 hasLocation W42255524254 @default.
• W4225552425 hasOpenAccess W4225552425 @default.
• W4225552425 hasPrimaryLocation W42255524251 @default.
• W4225552425 hasRelatedWork W2022229528 @default.
• W4225552425 hasRelatedWork W2095950656 @default.
• W4225552425 hasRelatedWork W2224319365 @default.
• W4225552425 hasRelatedWork W2297592050 @default.
• W4225552425 hasRelatedWork W2340462751 @default.
• W4225552425 hasRelatedWork W2356105190 @default.
• W4225552425 hasRelatedWork W2364646700 @default.
• W4225552425 hasRelatedWork W2899615166 @default.
• W4225552425 hasRelatedWork W3130591221 @default.
• W4225552425 hasRelatedWork W3196332669 @default.
• W4225552425 hasVolume "Volume 14" @default.
• W4225552425 isParatext "false" @default.

• next